Pharmacogenetic testing was associated with nearly a two-fold (89%) increase in remission rates compared to treatment as usual in a Centre for Addiction and Mental Health- (CAMH-)led clinical study just published in the journal ...
Mar 29, 2022
0
49
In the summer of 2020, Texas Tech University's Office of Research Commercialization filed a patent application and applied for the COVID-19 Prioritized Examination Pilot Program with the U.S. Patent and Trade Office.
Mar 28, 2022
0
6
In 2018, the U.S. Food and Drug Administration approved the first prescription medication derived from cannabis sativa: Epidiolex. Used to treat seizures, Epidiolex is purified formulation of cannabidiol (CBD) and has been ...
Mar 25, 2022
0
100
Mayo Clinic researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. Nearly 1 million people in the U.S. are affected by MS, according ...
Mar 24, 2022
0
17
Scientists at the University of North Carolina at Chapel Hill are testing a new route for remdesivir, a pill form of the COVID-19 treatment that's given to half of all hospitalized patients with the disease.
Mar 22, 2022
0
79
Preclinical studies, the kind that scientists perform before testing in humans, don't get as much attention as their clinical counterparts. But they are the vital first steps to eventual treatments and cures. It's important ...
Mar 21, 2022
0
2
Most women experience nausea and vomiting during pregnancy, but a condition known as hyperemesis gravidarum (HG), which affects up to 2% of pregnant women, causes nausea and vomiting so severe that it can lead to starvation, ...
Mar 21, 2022
0
36
Only 1 in 3 patients are diagnosed with broken bones in the back due to osteoporosis. One reason is that medical staff find it difficult to know who should have a back X-ray. To help address this important diagnostic care ...
Mar 14, 2022
0
52
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings, according to a recently published, peer-reviewed study.
Mar 10, 2022
0
0
